Silverarc Capital Management LLC comprou ações da Scholar Rock Holding Co. Silverarc Capital Management LLC purchased shares of Scholar Rock Holding Co.

Silverarc Capital Management LLC comprou 9.711 ações da Scholar Rock Holding Co. (NASDAQ:SRRK) por um investimento de US$ 69.000 no terceiro trimestre. Silverarc Capital Management LLC purchased 9,711 shares of Scholar Rock Holding Co. (NASDAQ:SRRK) for a $69,000 investment in Q3. Outros investidores, como o Royal Bank of Canada e o Amalgamated Bank, também aumentaram as suas participações na SRRK. Other investors, such as Royal Bank of Canada and Amalgamated Bank, also increased their stakes in SRRK. Silverarc possui participações em várias empresas de biotecnologia, incluindo Evogene, Roivant Sciences, Karyopharm Therapeutics, Aerovate Therapeutics e Viridian Therapeutics. Silverarc has holdings in various biotech companies, including Evogene, Roivant Sciences, Karyopharm Therapeutics, Aerovate Therapeutics, and Viridian Therapeutics.